Postnatal ontogeny of GABAB binding in rat brain by Turgeon, Sarah M. & Albin, Roger L.
Pergamon 0306-4522(94)E0193-8 
Neuroscience Vol. 62, No. 2, pp, 601413, 1994 
Elsevier Science Ltd 
Copyright 0 1994 IBRO 
Printed in Great Britain. All rights reserved 
0306-4522/94 $7 00 + 0.00 
POSTNATAL ONTOGENY OF GABA, BINDING IN RAT 
BRAIN 
S. M. TURGEON and R. L. ALBIN* 
Neuroscience Program and Department of Neurology. University of Michigan, Ann Arbor, 
MI 48109, U.S.A. 
Abstract-The postnatal development of GABA, binding sites in rat brain was studied by quantitative 
receptor autoradiography using [‘H]GABA under selective conditions. Binding levels peak at regionally 
specific times during the first three weeks of life and then decline to adult levels. GABA, binding peaked 
in the globus pallidus, vestibular and spinal trigeminal nuclei, and the CA3 region of the hippocampus 
at postnatal day 3; in the striatum, nucleus accumbens, inferior olive, septum, dentate gyms and CA1 
region of the hippocampus at postnatal day 7; in the neocortex and thalamus at postnatal day 14; and 
in the medial geniculate at postnatal day 21. Following these regionally specific peaks, binding decreased 
to postnatal day 28 levels. Further significant decreases in binding were observed in all regions examined 
between postnatal day 28 and adulthood. Comparisons of binding site pharmacology reveal equipotent 
displacement of GABA, binding by several competitive agonists and antagonists in postnatal day 7 and 
adult rat brain, indicating that immature and adult binding sites have similar pharmacological properties 
with regard to these compounds. The GABA, receptor antagonist CGP 54626A, however, inhibited 
binding more potently in the postnatal day 7 thalamus and neocortex than in these areas in the adult brain. 
The guanyl nucleotide analogue guanosine 5’-O-(3-thiotriphasphate) inhibited GABA, binding exten- 
sively in both postnatal day 7 and adult brain. The non-competitive antagonist zinc also inhibited GABA, 
binding at both ages and was more potent in postnatal day 7 brain than in adult brain, Saturation analyses 
reveal two binding sites with similar affinities in both immature and adult rat brain, indicating that 
postnatal modulation of GABA, binding reflects changes in binding site density rather than modulation 
of binding site affinity. While immature GABA, binding sites share most pharmacological characteristics 
with adult binding sites and appear to be coupled IO G-proteins at an early age, their interactions with 
zinc and CGP 54626A suggest that GABA. binding sites in immature brain may have a distinct 
pharmacological profile. __ 
Our data suggest significant regional and pharmacological changes in GABA, binding during 
development. The implications of these findings are discussed with regards to a possible role of GABA, 
receptors in the development of the central nervous system. 
GABA is the predominant inhibitory neurotrans- 
mitter of the CNS. The inhibitory actions of 
GABA are mediated by two types of receptors, 
the GABA, receptor and the GABA, receptor. 
While the GABA, receptor has been extensively 
described and investigated, the GABA, receptor 
is less well understood. In the mature brain, acti- 
vation of GABA, receptors can inhibit the release of 
neurotransmitters” and hyperpolarize postsynaptic 
neurons.so*5’ The activation of GABA, receptors 
results in various cellular responses, including alter- 
ations in ion channel conductances”J5 and modu- 
lation of intracellular second messenger systems, such 
as adenylyl cyclase.‘2~37~69,70 
A number of studies have revealed modulation of 
neurotransmitter receptor expression during early 
‘To whom correspondence should be addressed. 
Abbreviations: AMPA, a-amino-3-hydroxy-S-methyl-iso- 
xazole-Cpropionate; 3-APA, 3-aminopropylphospho- 
nous acid; GAD, glutamate decarboxylase; GTP-y-S, 
guanosine 5’-0-(3-thiotriphasphate); P, postnatal day. 
postnatal development. Benzodiazepine,?’ kainatet’ 
a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic 
acid (AMPA), and N-methyl-D-aspartate’4S4’*6’ 
binding all exhibit regionally specific peaks during the 
first three postnatal weeks before declining to adult 
levels. The development of binding to a subtype of 
glutamate receptor, now known to be a metabotropic 
receptor, Is is also modulated in a regionally specific 
manner. Binding in some regions decreases through- 
out development, binding in other regions increases, 
while in some regions binding peaks and then declines 
to adult levels.28~3B Immunohistochemical studies 
have shown developmental modulation of both quan- 
tity and distribution of neocortical glycine receptor 
a-subunits, with a transient peak in immunoreactivity 
around postnatal day (p) 14.6 Finally, transiently 
high levels of GABA, binding have been observed 
in various brain stem regions, peaking at or before 
PlO and then declining to adult levels.72 In all of 
these studies, the transient peaks in binding are 
suggested to indicate a role of these receptors in 
development. 
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Our previous results indicate that GABA, binding 
follows a unique pattern of development as well. 
We have observed a peak in GABA, binding in 
the cerebellar molecular layer around the end of the 
second postnatal week, followed by a significant 
decrease in binding to adult levels. In addition, 
we observed transient expression of high levels of 
GABA, binding in the deep cerebellar nuclei during 
early postnatal life. ‘j While early investigations of 
G-protein coupling’ and neocortical electrophysio- 
logical responses”’ suggested that GABA, receptors 
are not functionally active until the second post- 
natal week, more recent evidence has shown that 
presynaptic GABA, receptor-mediated inhibition is 
present in somatosensory cortex by P7.r4 Functional 
postsynaptic GABA, receptors have also been ident- 
ified in rat hippocampal slices in the first postnatal 
week.‘6.26s35 In addition to their neurotransmitter 
function, GABA, receptors may also modulate 
neurite outgrowth in the CNS.46 
In an attempt to more fully characterize the post- 
natal ontogeny of the GABA, receptor expression, 
[‘HIGABA receptor autoradiography was used to 
describe postnatal modulation of GABA, binding 
in several forebrain and brainstem structures and to 
compare the pharmacology of GABA, receptors in 
immature (P7) and adult (P42-P52) rat brain. 
EXPERIMENTAL PROCEDURES 
Materials 
[]H]GABA (91.7 Ci/mmol) was obtained from Amersham 
(Arlington Heights, IL). Isoguvacine was purchased 
from Cambridge Research Chemicals (Cambridge, U.K.). 
( +)Baclofen was a gift from Dr R. Love11 (Ciba-Geigy, 
Summit, NJ). 3-Aminopropylphosphonous acid (3-APA; 
also known as 3-aminopropylphosphinic acid), phaclofen 
and 2-hydroxysaclofen were purchased from Tocris 
Neuramin (London, U.K.). CGP 35348 was donated by Drs 
H. Schroter and L. Maitre (Ciba-Geigy, Base], Switzerland). 
CGP 54626A was a gift of Dr S. .I- Mickel (Ciba-Geigy. 
Base], Switzerland). Guanosine 5’-O-(3-thiotriphosphate) 
(GTP-y-S) was purchased from Sigma (St Louis, MO). 
Anunals 
Adult male SpragueDawley rats (P42-P57) and pregnant 
Sprague-Dawley rats were purchased from Harlan Indus- 
tries (Indianapolis, IN). For binding studies, male pups were 
killed one day after birth (Pl), P3, P7, P14, P21 and P28. 
Pharmacology and saturation studies used male pups killed 
at P7-P8 and adults. 
Tissue preparation 
For autoradiography experiments, animals were decapi- 
tated and their brains were rapidly dissected and frozen in 
Lipshaw embedding matrix surrounded by powdered dry 
ice. Brains were mounted on cryotome chucks with Lipshaw 
embedding matrix. Serial sections (20 pm, in the horizontal 
or coronal plane) were cut on a Lipshaw cryostat at - 20°C 
and thaw-mounted onto gelatin-coated slides. In the devel- 
opment time course experiments, sections were tdkeu in 
four coronal planes: (i) the level of the nucleus accumbens; 
(ii) the level of the globus pallidus; (iii) the level of the 
thalamus and rostra1 hippocampus; and (iv) the level of 
the superior colliculus and medial geniculate (see Fig. I). 
Coronal sections at the level of the caudal brainstem were 
also examined. In the P29 vs adult and pharmacology 
experiments, brains were cut in the horizontal plane. 
Sections were stored for no longer than 24 h at -20’ C prior 
to assays. 
[‘HIGABA quanlifative uurorudiogruph~ 
GABA, binding sites were examined with 20 nM 
[‘HIGABA in the presence of 10 mM isoguvacine.” Sections 
were run in triplicate. Sections were prewashed for 30 min 
in buffer containing 50 mM Tris-Hdl and 2.5 mM CaCI, 
(pH 7.4 at +4”C) to remove endogenous ligand. and were 
then dried under a stream of cool air. Assay conditions 
involved a 45min incubation at +4”C with 20nM 
[‘HIGABA in 50 mM Tris-HCI and 2.5 mM CaCl, (pH 7.4 
at +4”C). In the pharmacolopv experiments. concentrations 
of 30nM to 1 mM f-hydrGxys&lofen, 3 PM to 1 mM 
phaclofen, 30 nM to 1 mM CGP 35348, 30pM to 1 /IM 
3-APA, 10 pM to 300nM CGP 54626A, 10 nM to IOObM 
GTP-y-S and 1 nM to 3mM zinc were included in the 
incubation mixture. Saturation experiments were performed 
by the method of isotopic dilution with total GABA con- 
centrations from 666pM to 33.3 gM. For concentration 
points at and below 33.3 nM, only [‘HIGABA was used. For 
concentration points above 33.3 nM, 33.3 nM [3H]GABA 
was diluted with non-radioactive GABA Non-specific bind- 
ing was determined by the addition of 100 uM ( + )baclofen. 
Following incubation, slides were removed individually 
and rinsed quickly three times with 3 ml buffer squirted 
from a repipetter and once with 3 ml 2.5% glutaraldehyde 
in acetone, and immediately blown dry with warm air. 
Slides were mounted in an X-ray cassette and apposed to 
tritium sensitive film (rH-Hyperlilm, Amersham) along with 
standards containing known amounts of radioactivity 
(ARC, Inc., St Louis, MO) for three to four weeks at t 4°C. 
Films were developed for 4 min in Kodak D-19, fixed and 
dried. 
Data analysis 
Ligand binding was quantified with computer-assisted 
densitometry using an MCID system (Imaging Research 
Inc., St Catherine’s, Ont.). To quantify ligand binding levels, 
the optical density of co-exposed standards was determined 
and a standard curve was generated by fitting standard 
optical density values to standard radioactivity values 
with a fourth-degree polynomial regression equation, as 
described previo;sly.ti Standards were commercial “‘C 
alastic standards (ARC Inc.. St Louis, MO), calibrated 
against previously described 3H-brain paste standards con- 
structed to give a known amount of radioactivity per mg 
protein.” Optical density readings were taken in regions of 
Fig. 1. Autoradiographs and graphs of [rH]GABA binding to GABA, binding sites at four coronal levels 
(see Experimental Procedures for details): level I (A), level II (B), level III (C) and level IV (D), within 
postnatal ages indicated in the bottom right corner of the autoradiographs. Representative postnatal ages 
were selected to best illustrate regional Peaks in binding. ANOVAs reveal significant differences in GABA, 
bindine across develoument in all reaions examined (P < 0.005). Post hoc analysis with a ScheRe F-test 
reveals GABA, bindmg significantlyWdifferent from P28 at PI and P3 in the n&cortex, P3, P7 and P14 
in the striatum. P3 and P7 in the sentum. PI. P3. P7 and P14 in the globus pallidus, Pl, P3, P7 and PI4 
in both CA1 and CA3, P3 and P7 h the dentate, P21 in the medialgenicuiate, and PI4 in the superior 
colliculus (P < 0.05). 
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Fig. 2. Autoradiographs of 13H]GABA binding to GABA binding sites in the media1 vestibuiar nucleus 
(MVestN), spinal trigeminal nucbus (SpTriN) and inferior olive (Inf Ohve) at P3 (A) and P28 (B). Also 
note extensive binding in the deep cerebelkr nuclei (DCN at P3 which is absent in adult brain.65 (C) 
Development of [%I]GABA binding to GABA, binding sites in the brainstem at PI (n = 6). P3 (n = 6). 
P7 (n = 6), P14 (n = 5), P21 (n = 4) and P28 (n = 4). ANOVAs reveal significant differences in GABA, 
binding across development in all regions examined (U < 0.001). *Pm hoc analysis with a Scheffe F-test 
reveals GABAB binding sign~~~ntiy different from PZ8 [F < 0.05). 
interest and converted to fmolimg protein values using the 
standard curve derived from the optical density values of 
the standards.” 
Ontogeny. In the first experiment, GABA, binding in 
PI-P28 brains was examined. Binding was assessed in the 
caudal brainstem and in each forebrain structure at the 
foilowing levels (described above in Tissue pmparation): 
cortex; ail levels, striatum; levels I and II, septum and 
nucleus accmnbens; level I, gfobus pallidus; level II, thala- 
mus and hippccampal regions; level III, and medial genicu- 
late and superior colliculus; level IV. In examining the 
development of the pattern of binding within the neocortex, 
oniy sections taken at levet I were analysed. 
In the second experiment, GABA, binding in P28 brains 
was compared to binding in adult brains. 
P~ur~ucoiogy. rc, values for the displacing ligands were 
calculated mathematically for four regions using a simple 
linear regression for Points between 10 and 90% of total 
binding plotted on a dose-response semi-log plot (Cricket 
Graph, Cricket Software, Malvern, PA). Saturation data 
were anaiysed using the computer program LIGAND 
(Biosoft, Ferguson, MO). LIGAND performed a statistical 
analysis of the residual variance of one vs two-site curve fits 
using a partial F-test. A two-site fit was considered to be 
preferable at sibilance levels of P K 0.05. 
RESULTS 
Qntogery of GABA, bring 
GABA, binding peaked at regionally specific 
times during postnatal development. Binding peaked 
in the globus pallidus and the CA3 region of the 
hippocampus at P3; in the striatum, nucleus accum- 
hens, inferior olive, septum, dentate gyrus and 
CA1 region of the hippocampus at P7; in the neo- 
cortex, thalamus and superior colliculus at P14; 
and in the medial geniculate at P21 (Fig. 1). 
GABA, binding peaked in the vestibular and spinal 
t~geminal nuclei at P3 and in the inferior otive at P7 
(Fig. 2). In addition, binding decreased significantly 
in all regions examined from P28 to adulthood 
(Table 1). 
The distribution of GABA, binding in the neo- 
cortex also changed during development (Fig. 3, 
Table 2). GABA, binding was assessed in the outer, 
middle and inner thirds of the cortex. At PI and P3, 
a band of high binding was observed at the oute~ost 
part of the cortex, corresponding to cortical layer I. 
At this age, binding in the middle and inner thirds of 
Table I. Comparison of pH]GABA binding to 
GABA, binding sites in P28 and adult forebrain 
regions @I = 3 at each age) 
P28 Adult 
Thalamus 426,s c 52.9 255.6 & 4.2 
Neocortex 355.8 & 30.9 216.5 & 14.1 
Striatum 82.9 i: 7.2 48.9 i 5.9 
Dentate 221.3 i 21.3 142.2 5 15.0 
CA1 103.9 * Il.5 60.3 + 1.1 
CA3 82.3 It 8.4 53.3 + 5.9 
Binding decreased significantly from P28 to 
adultho~ in all areas examined (P iO.05, 
Student’s f-test). 
GABA, receptor ontogeny 
Fig. 3. Autoradiographs of [‘H]GABA binding to GABA, binding sites in the neocortex at PI (A), P3 
(B), P7 (C). PI4 CD), P21 (Ef and P28 (F). Regional binding levels within the neocortex at these ages are 
presented in Table 2. Scale bar = 1 mm. 
the cortex was greater than binding in the remainder 
of the outer third, just under the layer I band of high 
binding. At P7, binding was essentially homogeneous 
throughout the cortex, with slightly higher levels in 
the middle third. From PI4 on, binding was greatest 
in the outer third and least in the inner third. These 
regional changes were supported by post hoc analyses 
(see Table 2 legend). 
Fhartnucoiogy of immature us ad& GAB& binding 
Regional IC,, values were the same in P7 and ad& 
brain for displacement of GABA, binding by the 
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competitive GABA, agonist 3-APA, and the com- 
petitive GABAB antagonists 2-hydroxysaclofen, CGP 
35348 and phaclofen (Table 3). The competition 
curves for displacement of GABA, binding by these 
compounds in P7 and adult brain were virtually 
superimposable (Fig. 4). The competitive GABA, 
antagonist, CGP 54626A,*,” also displaced binding 
equipotently in the cerebellum and hippocampus. 
However, in the neocortex and thalamus, CGP 
54626A inhibited GABA, binding with significantly 
greater potency in P7 brain than in adult brain 
(Fig. 5, Table 3). 
Both the guanyl nucleotide analogue GTP-y-S 
and the non-competitive antagonist zinc are more 
potent in immature brain than in adult brain 
(Fig. 6, Table 3). In addition, the regionally specific 
enhancement of GABA, binding by low micromolar 
concentrations of zinc seen in the cerebellar molecu- 
lar layer, neocortex and hippocampus of adult brainW 
was not observed in any region of the P7 brain 
(Fig. 6B). 
Saturation studies reveal two affinity sites for both 
P7 and adult GABA, binding sites (Fig. 7). K, and 
B,,,,, values for high- and low-affinity binding sites in 
the cerebellum, neocortex and thalamus of P7 and 
adult brain are presented in Table 4. 
DISCUSSlON 
Ontogeny of GABA, binding 
GABA, binding increases just after birth, peaks 
at regionally specific times during the first two post- 
natal weeks and then decreases with adulthood. 
In interpreting these data, we must address the 
possible effect of developmental changes in tritium 
quenching on the observed changes in GABA, bind- 
ing. Tritium emissions are absorbed to a greater 
extent by white matter than gray matter such that 
increased myelination during development would 
result in decreased tritium emissions. Therefore, 
the post-peak decreases in [‘H]GABA binding to 
GABA, binding sites could theoretically be due 
to increased myelination during development, 
However, decreases in tritium emissions from ~14 to 
adult are of the order of l-14%,” while decreases 
in GABA, binding are approximately 40-50%. 
Thus, the effect of tritium quenching is not great 
enough to account for the decreases in GABA, 
binding observed during development. One region in 
which tritium quenching does appear to be almost 
great enough to account for the changes in GABA, 
binding seen during development is the globus pal- 
lidus.” However, previous investigations have shown 
that binding with [‘Qglutamate, the emissions of 
which are not affected by myelination. gives the 
same results as binding with 13H]glutamate in the 
globus pallidus2’ and hippocampus, suggesting that 
quenching may not explain the decrease in binding 
we observed in these regions. In addition, we have 
previously investigated the effect of tritium quenching 
on decreases in binding in the deep cerebellar 
nuclei and found that binding with [14C]GABA and 
[‘HIGABA gives the same results.65 Furthermore, 
increases in quenching in regions such as the neo- 
cortex and thalamus from P5 to P14 suggest that we 
may be underestimating the magnitude of increases 
in GABA, binding from birth to P14 in these 
regions. 
Our findings concerning the changes in GABA, 
binding site development are in partial agreement 
with the little work that has been done in this area. 
A study of GABAB binding in the cerebellum, hippo- 
campus and substantia nigra reports no changes in 
the affinity of GABA, binding sites for [‘H]GABA 
across development, but higher B,,,,, values for 
GABAk binding in Pl4-P17 pups than in adults 
in the substantia nigra and lower B,,,,,, values for 
GABA, binding in pups in the hippocampus and 
cerebellum.27 While we see similar changes in the 
substantia nigra (unpublished observations), we also 
see decreased binding in the cerebellum and hippo- 
campus over the course of development. The reason 
for this discrepancy is not clear. The previous 
study was done in homogenates and therefore 
Table 2. Comparison of rH]GABA binding to GABA, binding sites in the 
neocortex at PI (n = 4), P3 (n = 4) P7 (n = 4) P14 (n =4), P21 (n = 4) and 
P28 (n = 3) 
Layer I 0 M I 
Pl 164.4 + 22.8 127.2 & 14.8 184.3 + 9.1 203.0 f 9.0 
P3 289.1 + 14.3 177.0 k 10.6 269.5 f 14.0 275.8 f 11.1 
P7 360.2 + 9.4 417.4 * 10.2 376.1 jI 10.8 
P14 591.2 + 70.5 521.5 + 51.8 416.7 + 40.3 
P21 531.4k221.3 453.7 & 23.3 345.9 + 23.1 
P28 526.3 f 47.1 402.4 & 35.3 303.7 + 25.4 
Binding was analysed in layer I (LI) at Pl and P3, the outer third of the cortex 
(not including layer I at Pl and P3; 0), the middle third of the cortex (M) 
and the inner third of the cortex (I) as indicated on the autoradiograms 
in Fig. 3. ANOVAs reveal significant differences in GABAs binding across 
the different regions of the neocortex at all ages except PI4 (P < 0.05). 
*Post hoc analysis with a Scheffe F-test reveals significant differences in 
GABA, binding in LI vs 0 at P3, 0 vs M at P3 and P7, M vs I at P21, 
and 0 vs I at Pl, P3, P21 and P28 (P i 0.05). 
GABA, receptor ontogeny 





Fig. 4. Inhibition of [-‘H]GABA binding to P7 and adult 
GABA, binding sites by the GABA, agonist 3-APA and the 
GABA, antagonists 2-hydroxysaclofen (2-O&S), phaclofen 
and CGP 35348. Binding was evaluated in various forebrain 
and cerebellar regions (n = 3 at each age). Representative 
curves from the deep eerebellar nuclei of P7 brain and the 
cerebellar molecular layer of adult brain are shown. These 
regions were chosen because of the high level of binding and 
to contrast binding to a purely transient population of 
binding sites with an adult population. rcso values for other 
regions are presented in Table I. No significant differences 
in rcso vahtes were observed (see Table 1). 
methodological differences may have contributed to 
the observed discrepancies. 
Earlier studies concerning developmental changes 
in GABA receptor binding report increased 
[3H]GABA binding during developmentis due to a 
change in receptor number.* However, these studies 
used binding conditions which favour GABA, bind- 
ing. A more recent investigation of GABA,, binding 
using [3H]muscimol receptor autoradiography has 
indicated that in many brain stem regions, GABA, 
binding peaks at or before PIO, while binding in other 
rostra1 brain regions increases with age and peaks 
at or after PZl.‘* Our results concerning GABAa 
binding indicate a similar early peak in the spinal 
trigeminal nucleus, vestibular nucleus and inferior 
olive. However, in the other brain regions examined, 
adult GABA, binding levels peak around P21 and 
decline only slightly to adult levels, while GABA, 
binding levels peak earlier and decrease signifi- 
cantly to adult levefs. The development of GABA, 
and GABA, binding site expression seems to be 
independent of one another. 
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Fig. 5. Inhibition of [jH]GABA binding to GABA, binding sites by the GABA, antagonist CGP 54626A 
in the deep cerebellar nuclei of P7 brain and the cerebellar molecular layer of adult brain (DCN/ML), 
and the dentate gyrus, thalamus and neocortex of P7 and adult brain (n = 3 at each age). IC,,‘s in P7 brain 
were significantly lower than in adult brain in the neocortex and thalamus (P c; 0.05: see Table 3). 
The ontogeny of GABA, binding does not seem 
to correlate with developmental changes in various 
neurochemical markers of GABAergic synaptic 
function. Glutamate decarboxylase (GAD), the 
enzyme mediating GABA synthesis, is detectable 
in embryonic cortex and increases to adult levels 
between the third and fourth postnatal weeks.‘8~‘9~60 
The development of GABA-transaminase activity, 
the enzyme mediating GABA catabolism, also 
increases with development, maintaining a fairly 
constant GAD/GABA-transaminase ratio through- 
out development.@’ In addition, GABA levelq2’ high- 
affinity GABA uptake’s~56 and K+-stimulated 
Cal+ -dependent GABA release from cortical slices” 
all increase during postnatal development. Unlike 
these other GABAergic parameters, which exhibit 
a generalized increase with maturity, GABA, 
binding is high at birth, increases to regionally 
specific peaks and then decreases between P28 and 
adulthood. 
The development of GABA, binding may correlate 
with periods of morphological and connectional 
development in certain regions. In the neocortex, 
developmental changes in GABA, binding site distri- 
bution seem to coincide with patterns of synapto- 
genesis. At Pl and P3, a thin band of GABA, binding 
was observed around the outer cortex, corresponding 
with cortical layer I. 68 From PI and P4, Blue and 
Parnavelas’ found synapses predominantly in layer I 
and in the subplate region of cortex, corresponding to 
the areas of greatest GABA, binding. At P8, approxi- 
mately when cortical GABA, binding is more evenly 
distributed, the concentration of synapses shifts to 
the more superficial layers and, by P14, the majority 
of synapses are in the superficial layers, as are the 
majority of GABA, binding sites. 
Overall, GABA, binding in the neocortex peaked 
around the end of the second postnatal week, co- 
inciding with the attainment of adult features in 
the cortical layers,23,68 and the refining of corticocor- 
tical projections by elimination of axon collaterals/ 
dendrites.68 PI4 also marks the point at which we 
observed the adult distribution of GABA, binding, 
with the highest levels of binding in the outer layers 
of the cortex. The cytoarchitectonic changes which 
take place after PI4 are reported to be due to a 
further decrease in cell density due to increases in the 
neuropil.23 Therefore, the decreases in GABA, bind- 
ing following the peak in binding at PI4 could be due 
to decreased cell density and/or the elimination 
of axon collaterals or dendrites containing GABA, 
receptors 
GABA, receptor ontogeny 609 
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Fig. 6. Modulation of [‘HIGABA binding to GABA, bind- 
ing sites by the guanyl nucleotide analogue GTP-y-S in the 
deep cerebellar nuclei of P7 brain and the cerebellar molecu- 
lar layer of adult brain (A) and by the non-competitive 
GABA, antagonist zinc in the same regions (B; n = 3 at 
each age). lcg values for both compounds are significantly 
lower in P7 brain than in adult brain (P -Z 0.05; see Table 
3). Note also the robust enhancement of GABA, binding by 
lower doses of zinc in the adult brain which is absent in the 
P7 brain. 
GABA, binding in the thalamus also peaks around 
P14. We do not know the cellular localization of these 
binding sites; however, this peak in binding corre- 
sponds to the point at which the lemniscal afferents 
have developed their extensive presynaptic arbors.” 
In addition, the reciprocal projections from the pre- 
frontal cortex to the thalamus appear at P9 and could 
therefore contribute to the increase in GABA, bind- 
ing, should GABA, binding sites be localized to these 
elements.67 
The disappearance of transient projections to 
and from the thalamus may explain the decrease in 
GABA, binding in the thalamus after P14. A con- 
tralateral thalamocortical projection has been ident- 
ified in neonatal rats which undergoes substantial 
reduction by adulthood!* However, neither 
the precise time course nor the fate of the transiently 
projecting cells (i.e. cell death, elimination of 
branches or transformation into local circuit neur- 
ons) has been determined. In addition, afferent 
projections from the dorsal column nuclei, deep 
cerebellar nuclei and inferior colliculus are much 
more extensive at birth than in mature rats.“ HOW- 
ever, only neonatal and mature (P30) rats were 
examined, so we cannot determine how closely this 
neuroanatomical change correlates with the change in 
GABA, binding in the thalamus. 
GABAs binding in the hippocampus precedes the 
appearance of many markers of GABAergic synaptic 
transmission. Significant amounts of GABAs binding 
are present in all hippocampal regions at birth, while 
GAD-positive neurons have been first observed at P4 
and GABA-positive neurons do not appear until P6.59 
The early appearance of GABA, binding sites 
suggests a non-synaptic role for these sites in the 
developing hippocampus. The presence of GABA, 
binding sites also precedes the earliest observation of 
GABA, receptor-mediated responses in the hippo- 
campus, found at P6,26 and recurrent inhibition in- 
volving both GABA, and GABA, receptor-mediated 
responses seen around PS in CA3 and P9 in CAl.62 
The presence of GABA, binding sites before the 
onset of inhibitory neurotransmission in the hippo- 
campus also supports a non-synaptic function for 
these binding sites in the immature brain. 
Evidence is accumulating for the developmental 
role for GABA in the CNS. The developmental 
increase in GAD activity precedes the development of 
GABAergic synapses, suggesting a non-synaptic 
function for early GABA production.‘,” GAD has 
also been localized to growth cone processes in 
developing rodent cerebellum,” suggesting a develop- 
mental role for GABA in the immature brain. In 
addition, recent reports have implicated a synapto- 
genie action for GABA in the developing brain. The 
presence of GABA will evoke the development of 
low-affinity GABA receptors45 and will increase the 
number of neurite-extending cells and density 
of intracellular components”’ in cultured cerebellar 
granule cells. In vivo, increased extracellular GABA 
-- 
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Fig. 7. Saturation analysis of [‘HIGABA binding to GABA, 
binding sites reveals high- and low-affinity GABA, binding 
sites in immature and adult brain (n = 6 at each age). 
A two-site fit was statistically preferred at both ages in all 
regions examined as determined by a partial F-test using the 
LIGAND program (P < 0.001). Binding was analyzed in 
the deep cerebellar nuclei of P7 brain and the cerebellar 
molecular layer of adult brain (curves shown), in the 
thalamus and in the neocortex. 
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Table 4. K, and I$,,, values for high (I) and low (II) affinity GABA, binding 
sites in the deep czrebe-liar nuclei, neocortex and thalamus of P7 rat brain, and 
the cerebellar molecuiar layer, neocortex and tbalamus of adult rat brain 
DCN!ML Neocortex Thalamus 
P? Adult P7 Adult -P7 Adult 
G, WW 31.7 16.7 24.4 26.0 25.2 
Bmax, (fM) 792 415 299 281 718 
&,, (nW 501 478 1120 1050 416 
B W) InaXll 1680 1940 1360 2000 1430 





concentrations by nipecotic acid treatment result in 
increased GABA binding as we11.40.4’ However, all 
of these effects seem to be mediated by GABA, 
receptors. 
While evidence exists for GABA, receptor-medi- 
ated synaptogenesis in adult tissue,5! during devetop- 
ment GABA, receptors may mediate inhibition of 
neurite outgrowth. GABA can increase neurite out- 
growth in cultured embryonic chick tectum in serum- 
containing medium; however, in serum-free medium 
GABA inhibits neurite outgrowth.4* GABA may be 
acting on GABA, receptors in the presence of serum 
and on GABA, receptors in the absence of serum. 
In addition, the GABA, agonist baclofen inhibited 
neurite outgrowth in serum-free medium, while the 
GABA, antagonist phaclofen enhanced outgrowth 
under these conditions.46 
The presence of high levels of GAflA, binding 
which precede a fully developed GABAergic system 
and then decrease into adulthood suggest a role for 
these receptors in the development of the CNS. In 
addition, the regionally specific manner in which 
GABA, binding peaks in the rat brain suggests a 
correlation between changes in GABA, binding and 
regional developmental profiles. 
Pharmacology of immature OS adult GABA, binding 
Most of the competitive GABA, ligands in- 
vestigated displace GABA, binding with approxi- 
mately the same potency in both immature and 
adult brain. These results indicate that [3H]GABA 
binding under these conditions is identifying the 
same GABAa binding site in both groups. How- 
ever, one of the ligands examined, the potent 
competitive GABA, antagonist CGP 54626A, 
displaced binding equipotently in some regions but 
was signi~cantIy more potent in the immature 
brain at displacing binding in the thalamus and 
neocortex. Evidence is accumulating for hetero- 
geneity of GABA, receptors in the CNS.‘0.‘2.‘4,S8 This 
hypothesis is supported by the discovery of a ligand 
that displaces GABA, binding differently in some 
regions of immature and adult brain and similarly in 
other regions. 
Zinc was also more potent at displacing GABAs 
binding in immature brain than in adult brain. 
Zinc inhibits GABA, binding in a non-competitive 
manner in adult brai@ and may modulate GABA, 
receptor function. 73 In addition, zinc has a biphasic 
effect on GABA, binding in adult brain, enhancing 
binding at low doses and inhibiting binding at higher 
doses (Fig. 7).@ This effect was not observed in any 
region in the immature brains. The difference in 
potency, combined with the absence of low dose 
zinc-induced enhancement of GABA, binding in the 
immature brain, also suggests that early postnatal 
GABA, binding sites differ in some respects from the 
adult binding sites. 
GTP-g-S inhibits GABA, binding in both young 
and adult animals, consistent with functional linkage 
to G-proteins. The observation that GTP-1)-S reduces 
binding to approximately 30% of total binding 
suggests that a high percentage of GABA, binding is 
in the high-affinity state. Our findings are not in 
agreement with a previous report of the effects of 
~anyI nucleotide analogues on GABA, binding in 
young and adult brain. AI-Dahan and Thalmann’ 
report increased inhibition of GABA, binding 
by GTP-y -S during development, while we see a 
small but statistically signiticant decrease in GTP-y-S 
inhibition of binding from P7 to adulthood. How- 
ever, the previous study compared Pl brain to adult 
brain, used detergent-treated homo~nates and used 
[‘Hlbaclofen instead of [‘H]GABA. The discrepancy 
could be due to methodological differences and/or 
developmental changes in baclofen binding to the 
GABA, receptor. 
Two affinity sites for GABA, binding were 
observed in both immature and adult brain. K, 
values for both sites were essentiafly the same at both 
developmental time points, but the B,,, values for the 
high-affinity site were slightly higher in immature 
brain. Slight differences in KD value for GABA, 
binding were observed in the immature deep cerebel- 
lar nuclei and the adult cerebeliar molecular layer. 
while &, values for immature and adult thalamus and 
neocortex were virtually indistinguishable. Some pre- 
vious saturation studies reveal a single affinity site 
with K,‘s in the low to mid-nanomolar rangc.i.‘3~‘7~3’.4’ 
While our report of a two-site fit for GABA, binding 
is in contrast to the previous finding of a single 
GABA, binding site using the same assay,” the 
previous study assessed binding over a considerably 
smaller range of GABA concentrations. In addition, 
we have obtained similar results in subsequent studies 
(unpublished data), as have other studies which 
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report two affinity states for the GABA, binding 
site with similar K,‘s to those reported here.3,52,6’ 
A two-site fit is consistent with the nature of G- 
protein-coupled receptors. 
The observation of regional- and age-dependent 
differences in GABA, binding site pharmacology 
between immature and adult brain suggests the 
presence of multiple subtypes of GABA, receptors. 
Multiple isoforms of glycine: N-methyl-o-aspar- 
tate:” AMPAJ’ and GABA, receptors3n have been 
discovered which undergo regionally specific changes 
in their distribution during early postnatal develop 
ment. Based on our results, we would predict a 
similar profile for GABA, receptors. 
CONCLUSIONS 
Taken together, our data suggest significant onto- 
genetic changes in the GABA, receptor. Regionally 
specific changes in GABA, receptor binding during 
development appear to coincide with synaptogenic 
and organizational events, suggesting a role for 
GABA, receptors in the development of the CNS. 
In addition, the presence of some pha~acologi~l 
differences between immature and adult GABA, 
binding sites suggests that varying proportions of 
receptor subtypes exist at these two stages of life. 
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